Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Biologic or vaccine
Remove filter for
Last updated: April 2022
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
AlertHealth professional risk communication | 2022-04-14